Crossref
EPH59 AGE AND GENDER HETEROGENEITY IN ADVERSE DRUG REACTIONS ASSOCIATED WITH HEMP USE: EVIDENCE FROM THE FDA PHARMACOVIGILANCE DATA IN THE LAST TWO DECADES
Value in Health · 2026-06 · 29 (6) · S175
DOI: 10.1016/j.jval.2026.03.892 ↗Kurz gefasst
Fachartikel in der Zeitschrift Value in Health, 2026-06. Verfasst von Chengwen Teng und 3 weiteren Autor:innen.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Teng, C., Wu, J., Yuan, J., & Lu, Z. K. (2026). EPH59 AGE AND GENDER HETEROGENEITY IN ADVERSE DRUG REACTIONS ASSOCIATED WITH HEMP USE: EVIDENCE FROM THE FDA PHARMACOVIGILANCE DATA IN THE LAST TWO DECADES. Value in Health, 29(6), S175. https://doi.org/10.1016/j.jval.2026.03.892
Vancouver
Teng C, Wu J, Yuan J, Lu ZK. EPH59 AGE AND GENDER HETEROGENEITY IN ADVERSE DRUG REACTIONS ASSOCIATED WITH HEMP USE: EVIDENCE FROM THE FDA PHARMACOVIGILANCE DATA IN THE LAST TWO DECADES. Value in Health. 2026;29(6):S175. doi:10.1016/j.jval.2026.03.892
BibTeX
@article{Teng2026,
author = {Teng, Chengwen and Wu, Jun and Yuan, Jing and Lu, Z. Kevin},
title = {EPH59 AGE AND GENDER HETEROGENEITY IN ADVERSE DRUG REACTIONS ASSOCIATED WITH HEMP USE: EVIDENCE FROM THE FDA PHARMACOVIGILANCE DATA IN THE LAST TWO DECADES},
journal = {Value in Health},
year = {2026},
volume = {29},
number = {6},
pages = {S175},
doi = {10.1016/j.jval.2026.03.892}
}
EUVIMED